Therapeutic Class
Bayer licenses lipid nanoparticle tech for gene therapy
Therapeutic ClassBayer licenses lipid nanoparticle tech for gene therapyBayer licenses lipid nanoparticle tech for gene therapy
Bayer has licensed lipid nanoparticle (LNP) technology from Acuitas Therapeutics to develop in vivo gene editing programs.